281 related articles for article (PubMed ID: 31935761)
1. Home Self-Administration of Biologics - A German Survey among Omalizumab-Treated Patients with Severe Asthma and their Treating Physicians.
Timmermann H; Mailänder C
Pneumologie; 2020 Feb; 74(2):103-111. PubMed ID: 31935761
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
[TBL] [Abstract][Full Text] [Related]
3. The potential of biologics for the treatment of asthma.
Pelaia G; Vatrella A; Maselli R
Nat Rev Drug Discov; 2012 Dec; 11(12):958-72. PubMed ID: 23197041
[TBL] [Abstract][Full Text] [Related]
4. Biological agents for severe asthma: the evolution of the at-home self-injection approach.
Lombardi C; Bagnasco D; Passalacqua G
Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):421-427. PubMed ID: 32590510
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of omalizumab in pre-filled syringes in patients with allergic (IgE-mediated) asthma.
Somerville L; Bardelas J; Viegas A; D'Andrea P; Blogg M; Peachey G
Curr Med Res Opin; 2014 Jan; 30(1):59-66. PubMed ID: 24028677
[TBL] [Abstract][Full Text] [Related]
6. Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab.
Chen H; Eisner MD; Haselkorn T; Trzaskoma B
Respir Med; 2013 Jan; 107(1):60-7. PubMed ID: 23083840
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab as add-on therapy to inhaled steroids for asthma.
Hadj Tahar A
Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
[TBL] [Abstract][Full Text] [Related]
8. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
Huffaker MF; Phipatanakul W
Immunol Allergy Clin North Am; 2015 Feb; 35(1):129-44. PubMed ID: 25459581
[TBL] [Abstract][Full Text] [Related]
9. Switching between biologics in severe asthma patients. When the first choice is not proven to be the best.
Papaioannou AI; Fouka E; Papakosta D; Papiris S; Loukides S
Clin Exp Allergy; 2021 Feb; 51(2):221-227. PubMed ID: 33305478
[TBL] [Abstract][Full Text] [Related]
10. Biologics for paediatric severe asthma: trick or TREAT?
Saglani S; Bush A; Carroll W; Cunningham S; Fleming L; Gaillard E; Gupta A; Murray C; Nagakumar P; Paton J; Roberts G; Seddon P; Sinha I
Lancet Respir Med; 2019 Apr; 7(4):294-296. PubMed ID: 30824361
[No Abstract] [Full Text] [Related]
11. Promises and challenges of biologics for severe asthma.
Tan R; Liew MF; Lim HF; Leung BP; Wong WSF
Biochem Pharmacol; 2020 Sep; 179():114012. PubMed ID: 32389637
[TBL] [Abstract][Full Text] [Related]
12. Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control.
Molimard M; Mala L; Bourdeix I; Le Gros V
Respir Med; 2014 Apr; 108(4):571-6. PubMed ID: 24565601
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
Holgate S; Bousquet J; Wenzel S; Fox H; Liu J; Castellsague J
Curr Med Res Opin; 2001; 17(4):233-40. PubMed ID: 11922396
[TBL] [Abstract][Full Text] [Related]
14. Anti-IgE therapy for asthma: an audit at atertiary care centre in Saudi Arabia.
Weheba IM; Abdelsayed AM; Arnaout RK; Zeitouni MO; Mobaireek KF; AlHarthi TB; Mobeireek AF
Ann Saudi Med; 2018; 38(6):439-444. PubMed ID: 30531179
[TBL] [Abstract][Full Text] [Related]
15. Assessment of long-term omalizumab treatment in patients with severe allergic asthma long-term omalizumab treatment in severe asthma.
Özgür ES; Özge C; Ïlvan A; Naycı SA
J Asthma; 2013 Aug; 50(6):687-94. PubMed ID: 23557459
[TBL] [Abstract][Full Text] [Related]
16. Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey.
Deschildre A; Marguet C; Salleron J; Pin I; Rittié JL; Derelle J; Taam RA; Fayon M; Brouard J; Dubus JC; Siret D; Weiss L; Pouessel G; Beghin L; Just J
Eur Respir J; 2013 Nov; 42(5):1224-33. PubMed ID: 23520319
[TBL] [Abstract][Full Text] [Related]
17. Eligibility for treatment with omalizumab in Italy and Germany.
Buhl R; Marco AG; Cohen D; Canonica GW
Respir Med; 2014 Jan; 108(1):50-6. PubMed ID: 24315468
[TBL] [Abstract][Full Text] [Related]
18. Role of Biologics in Asthma.
McGregor MC; Krings JG; Nair P; Castro M
Am J Respir Crit Care Med; 2019 Feb; 199(4):433-445. PubMed ID: 30525902
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis.
Cunha FSD; Valle SOR; Elabras Filho J; Dortas Júnior SD; França AT
J Bras Pneumol; 2018; 44(5):439-441. PubMed ID: 30517345
[No Abstract] [Full Text] [Related]
20. [Retrospective analysis of omalizumab in patients with severe allergic asthma].
Padullés Zamora N; Comas Sugrañes D; Méndez Cabaleiro N; Figueras Suriol A; Jodar Masanes R
Farm Hosp; 2013; 37(5):399-405. PubMed ID: 24128103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
